Prognostic and onco-immunological value of immune-related eRNAs-driven genes in lung adenocarcinoma
CONCLUSION: Above all, we constructed a prognostic risk signature with favorable predictive capacity in LUAD, which was significantly associated with malignant features, immunosuppressive tumor microenvironment, and immunotherapy response and may provide clinical benefit in clinical decisions.PMID:38602568 | PMC:PMC11008071 | DOI:10.1007/s00432-024-05687-5
Source: Clinical Lung Cancer - Category: Cancer & Oncology Authors: Xuan Wu Xingru Zhao Chao Zhou Nan Wei Zhiwei Xu Xiaoju Zhang Source Type: research
More News: Adenocarcinoma | Allergy & Immunology | Cancer | Cancer & Oncology | Databases & Libraries | Genetics | Immunotherapy | Lung Cancer